The gift reduces insider concentration but Kaye still holds 34.68%, maintaining control. No change in stated purpose or demands. Monitor for any subsequent 13D amendments that could signal a shift in strategy or further distribution of shares.
Price Chart
How similar events traded
Executive Summary
Executive Chairman Jack Kaye gifted 1,600,000 ordinary shares of Davion Healthcare to four individuals on November 19, 2026, reducing his beneficial ownership from 10,268,948 to 8,668,948 shares (34.68% of outstanding). The gifts were made without consideration and Kaye retains no voting or dispositive power over the transferred shares. This is a de-escalation of his concentrated insider position but does not change his role as Executive Chairman or his stated intentions.
Key Financial Metrics
Key Facts
- Jack Kaye gifted 1,600,000 ordinary shares on November 19, 2026 via four separate bona fide gifts (500K, 500K, 300K, 300K shares)
- Beneficial ownership reduced from 10,268,948 to 8,668,948 shares (34.68% of 25M outstanding)
- No consideration received; no voting or dispositive power retained over gifted shares
- Kaye remains Executive Chairman and a director of Davion Healthcare
- Prior stake was 10,268,948 shares (approximately 41.1% based on 25M outstanding); this filing reduces it by ~6.4 percentage points
Financial Impact
1,600,000 ordinary shares transferred via gift; no cash consideration. At the $26M market cap and 25M shares outstanding, the gifted shares represent ~6.4% of the company, worth approximately $1.66M at the snapshot price.
Risk Factors
- Gifts could precede further insider selling or distribution, though no sale has occurred
- Reduced insider alignment may lower perceived commitment to shareholders
- No change in control or governance structure; Kaye remains Executive Chairman
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D/A Filing (Primary) | 0001683168-26-008975 |
| Document: 0001683168-26-008975-index.html | 0001683168-26-008975 |
| Document: 0001683168-26-008975.txt | 0001683168-26-008975 |
Track record
15 reports on DAVI
Filters
- Nov 20, 20261d ago SC 13D/A Neutral 3/10 Viewing Entry $1.14 Now $0.9000 −21.05% settles Dec 21
- Nov 17, 20264d ago 6-K Neutral 2/10 Entry $1.03 Now $0.9000 −12.62% settles Dec 16
- Nov 17, 20264d ago Press Release Neutral 3/10 Entry $1.03 Now $0.9000 −12.62% settles Dec 16
- Nov 16, 20265d ago 6-K Neutral 4/10 Entry $1.02 Now $0.9000 −11.76% settles Dec 15
- Nov 16, 20265d ago Press Release Neutral 4/10 Entry $1.02 Now $0.9000 −11.76% settles Dec 15
- Nov 9, 202612d ago 6-K Neutral 1/10 Entry $1.75 Now $0.9000 −48.57% settles Dec 8
- Nov 9, 202612d ago 6-K Neutral 2/10 Entry $1.75 Now $0.9000 −48.57% settles Dec 8
- Nov 6, 202615d ago Press Release Neutral 3/10 Entry $1.59 Now $0.9000 −43.40% settles Dec 7
- Oct 29, 202624d ago 6-K Neutral 5/10 Entry $2.69 Now $0.9000 −66.54% settles Nov 27
- Oct 29, 202624d ago Press Release Neutral 5/10 Entry $2.69 Now $0.9000 −66.54% settles Nov 27
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers